Financhill
Sell
38

URI Quote, Financials, Valuation and Earnings

Last price:
$713.50
Seasonality move :
6.44%
Day range:
$719.16 - $729.05
52-week range:
$533.70 - $896.98
Dividend yield:
0.9%
P/E ratio:
18.98x
P/S ratio:
3.25x
P/B ratio:
5.55x
Volume:
221.4K
Avg. volume:
519.8K
1-year change:
25.09%
Market cap:
$47.6B
Revenue:
$14.3B
EPS (TTM):
$38.26
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $9.4B $8.5B $9.7B $11.6B $14.3B
Revenue Growth (YoY) 16.21% -8.78% 13.9% 19.82% 23.11%
 
Cost of Revenues $5.7B $5.3B $5.9B $6.6B $8.5B
Gross Profit $3.7B $3.2B $3.9B $5B $5.8B
Gross Profit Margin 39.25% 37.32% 39.66% 42.91% 40.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1B $979M $1.2B $1.4B $1.5B
Other Inc / (Exp) -$9M -$9M -$12M $15M -$9M
Operating Expenses $1.5B $1.4B $1.6B $1.8B $2B
Operating Income $2.2B $1.8B $2.3B $3.2B $3.9B
 
Net Interest Expenses $648M $669M $424M $445M $635M
EBT. Incl. Unusual Items $1.5B $1.1B $1.8B $2.8B $3.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $340M $249M $460M $697M $787M
Net Income to Company $1.2B $890M $1.4B $2.1B $2.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.2B $890M $1.4B $2.1B $2.4B
 
Basic EPS (Cont. Ops) $15.18 $12.24 $19.14 $29.77 $35.40
Diluted EPS (Cont. Ops) $15.11 $12.20 $19.04 $29.65 $35.28
Weighted Average Basic Share $77.3M $72.7M $72.4M $70.7M $68.5M
Weighted Average Diluted Share $77.7M $72.9M $72.8M $71M $68.7M
 
EBITDA $4.2B $3.8B $4.3B $5.5B $6.6B
EBIT $2.2B $1.8B $2.3B $3.2B $3.8B
 
Revenue (Reported) $9.4B $8.5B $9.7B $11.6B $14.3B
Operating Income (Reported) $2.2B $1.8B $2.3B $3.2B $3.9B
Operating Income (Adjusted) $2.2B $1.8B $2.3B $3.2B $3.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.2B $2.6B $3.1B $3.8B $4B
Revenue Growth (YoY) -12.1% 18.7% 17.53% 23.4% 6.03%
 
Cost of Revenues $1.3B $1.5B $1.7B $2.2B $2.3B
Gross Profit $886M $1.1B $1.4B $1.6B $1.6B
Gross Profit Margin 40.51% 42.49% 44.77% 42.1% 41.28%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $232M $326M $356M $374M $416M
Other Inc / (Exp) -$4M $3M $2M $2M $4M
Operating Expenses $329M $424M $446M $481M $525M
Operating Income $557M $679M $920M $1.1B $1.1B
 
Net Interest Expenses $278M $132M $106M $163M $178M
EBT. Incl. Unusual Items $275M $550M $816M $943M $949M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $67M $141M $210M $240M $241M
Net Income to Company $208M $409M $606M $703M $708M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $208M $409M $606M $703M $708M
 
Basic EPS (Cont. Ops) $2.88 $5.65 $8.69 $10.30 $10.73
Diluted EPS (Cont. Ops) $2.87 $5.63 $8.66 $10.29 $10.70
Weighted Average Basic Share $72.2M $72.5M $69.9M $68.2M $66M
Weighted Average Diluted Share $72.4M $72.7M $70.1M $68.3M $66.2M
 
EBITDA $1B $1.2B $1.5B $1.8B $1.9B
EBIT $553M $682M $922M $1.1B $1.1B
 
Revenue (Reported) $2.2B $2.6B $3.1B $3.8B $4B
Operating Income (Reported) $557M $679M $920M $1.1B $1.1B
Operating Income (Adjusted) $553M $682M $922M $1.1B $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $8.7B $9.2B $11.1B $13.9B $15B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.4B $5.7B $6.5B $8.2B $8.9B
Gross Profit $3.3B $3.6B $4.7B $5.7B $6.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $989M $1.1B $1.3B $1.5B $1.6B
Other Inc / (Exp) -$3M -$7M $3M -$2M $5M
Operating Expenses $1.4B $1.5B $1.7B $1.9B $2B
Operating Income $1.9B $2.1B $3B $3.8B $4B
 
Net Interest Expenses $714M $456M $406M $606M $672M
EBT. Incl. Unusual Items $1.2B $1.6B $2.6B $3.2B $3.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $254M $387M $604M $820M $816M
Net Income to Company $931M $1.2B $1.9B $2.4B $2.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $931M $1.2B $1.9B $2.4B $2.6B
 
Basic EPS (Cont. Ops) $12.65 $16.60 $27.30 $34.61 $38.38
Diluted EPS (Cont. Ops) $12.62 $16.54 $27.22 $34.49 $38.26
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3.9B $4B $5.1B $6.5B $6.9B
EBIT $1.9B $2B $3B $3.8B $4.1B
 
Revenue (Reported) $8.7B $9.2B $11.1B $13.9B $15B
Operating Income (Reported) $1.9B $2.1B $3B $3.8B $4B
Operating Income (Adjusted) $1.9B $2B $3B $3.8B $4.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $6.3B $6.9B $8.3B $10.6B $11.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.9B $4.2B $4.8B $6.4B $6.7B
Gross Profit $2.3B $2.7B $3.5B $4.3B $4.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $721M $877M $1B $1.1B $1.2B
Other Inc / (Exp) -$5M -$3M $12M -$5M $9M
Operating Expenses $1B $1.2B $1.3B $1.5B $1.5B
Operating Income $1.3B $1.5B $2.2B $2.8B $3B
 
Net Interest Expenses $544M $331M $313M $474M $511M
EBT. Incl. Unusual Items $752M $1.2B $1.9B $2.3B $2.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $159M $297M $441M $564M $593M
Net Income to Company $593M $905M $1.5B $1.7B $1.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $593M $905M $1.5B $1.7B $1.9B
 
Basic EPS (Cont. Ops) $8.15 $12.49 $20.67 $25.40 $28.35
Diluted EPS (Cont. Ops) $8.13 $12.45 $20.61 $25.34 $28.28
Weighted Average Basic Share $218.4M $217.3M $213.4M $206.3M $199.8M
Weighted Average Diluted Share $219M $218.1M $214.1M $206.8M $200.3M
 
EBITDA $2.8B $3B $3.9B $4.9B $5.1B
EBIT $1.3B $1.5B $2.2B $2.8B $3B
 
Revenue (Reported) $6.3B $6.9B $8.3B $10.6B $11.3B
Operating Income (Reported) $1.3B $1.5B $2.2B $2.8B $3B
Operating Income (Adjusted) $1.3B $1.5B $2.2B $2.8B $3B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $52M $202M $144M $106M $363M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5B $1.3B $1.7B $2B $2.2B
Inventory $120M $125M $164M $232M $205M
Prepaid Expenses $39M $329M $103M $73M $68M
Other Current Assets $50M $42M $60M $73M $62M
Total Current Assets $1.8B $2B $2.2B $2.7B $2.9B
 
Property Plant And Equipment $11.1B $10B $12B $14.9B $16B
Long-Term Investments -- -- -- -- --
Goodwill $5.2B $5.2B $5.5B $6B $5.9B
Other Intangibles $895M $648M $615M $452M $670M
Other Long-Term Assets $19M $38M $42M $47M $43M
Total Assets $19B $17.9B $20.3B $24.2B $25.6B
 
Accounts Payable $454M $466M $816M $1.1B $905M
Accrued Expenses $229M $217M $221M $272M $325M
Current Portion Of Long-Term Debt $997M $704M $906M $161M $1.5B
Current Portion Of Capital Lease Obligations $178M $178M $202M $211M $249M
Other Current Liabilities $94M $77M $85M $137M $168M
Total Current Liabilities $2.2B $1.9B $2.6B $2.4B $3.6B
 
Long-Term Debt $10.4B $9B $8.8B $11.2B $10.1B
Capital Leases -- -- -- -- --
Total Liabilities $15.1B $13.3B $14.3B $17.1B $17.5B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$186M -$146M -$171M -$264M -$228M
Common Equity $3.8B $4.5B $6B $7.1B $8.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $3.8B $4.5B $6B $7.1B $8.1B
 
Total Liabilities and Equity $19B $17.9B $20.3B $24.2B $25.6B
Cash and Short Terms $52M $202M $144M $106M $363M
Total Debt $11.4B $9.7B $9.7B $11.4B $11.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $174M $320M $76M $284M $479M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.3B $1.6B $1.9B $2.3B $2.4B
Inventory $108M $166M $193M $201M $211M
Prepaid Expenses -- $44M -- $49M --
Other Current Assets $122M $62M $124M $65M $235M
Total Current Assets $1.7B $2.2B $2.3B $3B $3.3B
 
Property Plant And Equipment $10.3B $11.9B $13B $16.3B $17.5B
Long-Term Investments -- -- -- -- --
Goodwill $5.1B $5.5B $5.5B $5.8B $6.9B
Other Intangibles $701M $662M $500M $728M $694M
Other Long-Term Assets $30M $44M $47M $48M $48M
Total Assets $17.9B $20.3B $21.4B $25.8B $28.4B
 
Accounts Payable $541M $1.1B $1.1B $1.1B $1.2B
Accrued Expenses $675M $807M $972M $1.1B $1.3B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.9B $2.8B $2.3B $3.7B $4B
 
Long-Term Debt $9.4B $9.2B $9.8B $10.6B $11.9B
Capital Leases -- -- -- -- --
Total Liabilities $13.7B $14.8B $15.1B $18.1B $19.8B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$214M -$169M -$312M -$268M -$237M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.2B $5.5B $6.4B $7.8B $8.6B
 
Total Liabilities and Equity $17.9B $20.3B $21.4B $25.8B $28.4B
Cash and Short Terms $174M $320M $76M $284M $479M
Total Debt $10.1B $10.1B $9.9B $12B $13.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $1.2B $890M $1.4B $2.1B $2.4B
Depreciation & Amoritzation $2B $2B $2B $2.2B $2.8B
Stock-Based Compensation $61M $70M $119M $127M $94M
Change in Accounts Receivable $39M $218M -$300M -$329M -$167M
Change in Inventories -$8M -$5M $9M -$25M $19M
Cash From Operations $3B $2.7B $3.7B $4.4B $4.7B
 
Capital Expenditures $2.4B $1.2B $3.2B $3.7B $4.1B
Cash Acquisitions -$249M -$2M -$1.4B -$2.3B -$574M
Cash From Investing -$1.7B -$223M -$3.6B -$5B -$3B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$406M
Special Dividend Paid
Long-Term Debt Issued $9.3B $9.3B $8.4B $9.9B $8.6B
Long-Term Debt Repaid -$9.7B -$11.2B -$8.5B -$8.2B -$8.6B
Repurchase of Common Stock -$870M -$286M -$34M -$1.1B -$1.1B
Other Financing Activities -$28M -$23M -$8M -$24M --
Cash From Financing -$1.3B -$2.3B -$140M $552M -$1.5B
 
Beginning Cash (CF) $43M $52M $202M $144M $106M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9M $142M -$62M -$31M $254M
Ending Cash (CF) $52M $202M $144M $106M $363M
 
Levered Free Cash Flow $674M $1.5B $491M $743M $634M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $208M $409M $606M $703M $708M
Depreciation & Amoritzation $492M $510M $560M $695M $738M
Stock-Based Compensation $18M $33M $35M $23M $24M
Change in Accounts Receivable -$95M -$206M -$202M -$139M -$117M
Change in Inventories -- $6M $3M $17M $12M
Cash From Operations $827M $1.1B $1.1B $1.1B $1.2B
 
Capital Expenditures $475M $1.2B $1.2B $1.1B $1.4B
Cash Acquisitions -- -- -$11M $12M -$108M
Cash From Investing -$245M -$995M -$978M -$711M -$1.2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$100M -$107M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.6B $3.3B $2B $2.2B $2.8B
Long-Term Debt Repaid -$4.1B -$3.4B -$1.9B -$2.2B -$2.4B
Repurchase of Common Stock -$5M -$1M -$239M -$252M -$377M
Other Financing Activities -$13M -$8M -- -- --
Cash From Financing -$536M -$103M -$152M -$290M -$33M
 
Beginning Cash (CF) $127M $336M $68M $227M $467M
Foreign Exchange Rate Adjustment $1M -$5M -$4M -$4M $8M
Additions / Reductions $46M -$11M $12M $61M $4M
Ending Cash (CF) $174M $320M $76M $284M $479M
 
Levered Free Cash Flow $352M -$102M -$19M -$56M -$209M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $931M $1.2B $1.9B $2.4B $2.6B
Depreciation & Amoritzation $2B $1.9B $2.2B $2.7B $2.8B
Stock-Based Compensation $62M $113M $125M $104M $101M
Change in Accounts Receivable $271M -$208M -$337M -$322M $36M
Change in Inventories $21M -$9M -$32M $30M $2M
Cash From Operations $2.7B $3.4B $3.9B $4.5B $4.9B
 
Capital Expenditures $1.1B $2.7B $3.4B $4.4B $4.2B
Cash Acquisitions -$4M -$1.4B -$324M -$2.4B -$1.5B
Cash From Investing -$247M -$3.1B -$2.8B -$5.2B -$4.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$305M -$427M
Special Dividend Paid
Long-Term Debt Issued $10.4B $9B $6.6B $11.4B $11.6B
Long-Term Debt Repaid -$12.2B -$9.1B -$6.8B -$9.4B -$10.4B
Repurchase of Common Stock -$487M -$38M -$1.1B -$816M -$1.4B
Other Financing Activities -$33M -- -- -- --
Cash From Financing -$2.4B -$117M -$1.3B $858M -$652M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $113M $134M -$237M $214M $190M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.6B $713M $464M $144M $743M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $593M $905M $1.5B $1.7B $1.9B
Depreciation & Amoritzation $1.5B $1.5B $1.6B $2.1B $2.1B
Stock-Based Compensation $46M $89M $95M $72M $79M
Change in Accounts Receivable $202M -$224M -$261M -$254M -$51M
Change in Inventories $12M $8M -$33M $22M $5M
Cash From Operations $2.3B $3B $3.2B $3.3B $3.5B
 
Capital Expenditures $930M $2.5B $2.6B $3.3B $3.4B
Cash Acquisitions -$2M -$1.4B -$323M -$406M -$1.3B
Cash From Investing -$286M -$3.2B -$2.4B -$2.5B -$3.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -$305M -$326M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7.3B $7B $5.2B $6.7B $9.7B
Long-Term Debt Repaid -$8.8B -$6.7B -$5B -$6.2B -$8B
Repurchase of Common Stock -$281M -$33M -$1.1B -$806M -$1.2B
Other Financing Activities -$23M -$8M -$9M -- -$17M
Cash From Financing -$1.9B $295M -$874M -$568M $254M
 
Beginning Cash (CF) $692M $816M $313M $432M $1.3B
Foreign Exchange Rate Adjustment $1M $5M -$6M -$5M -$3M
Additions / Reductions $121M $113M -$62M $183M $119M
Ending Cash (CF) $814M $934M $245M $610M $1.4B
 
Levered Free Cash Flow $1.4B $571M $544M -$55M $54M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 7.1% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is down 0.89% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 3.16% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock